nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—ABCC2—Paclitaxel—kidney cancer	0.0729	0.112	CbGbCtD
Pranlukast—ABCC2—Sorafenib—kidney cancer	0.0647	0.0994	CbGbCtD
Pranlukast—ABCC2—Vinblastine—kidney cancer	0.0639	0.0982	CbGbCtD
Pranlukast—ABCC2—Vincristine—kidney cancer	0.0629	0.0965	CbGbCtD
Pranlukast—CYP3A4—Everolimus—kidney cancer	0.0614	0.0943	CbGbCtD
Pranlukast—ABCC2—Sunitinib—kidney cancer	0.0525	0.0805	CbGbCtD
Pranlukast—CYP3A4—Temsirolimus—kidney cancer	0.0415	0.0637	CbGbCtD
Pranlukast—ABCC2—Doxorubicin—kidney cancer	0.0393	0.0603	CbGbCtD
Pranlukast—CYP2C9—Capecitabine—kidney cancer	0.0391	0.06	CbGbCtD
Pranlukast—CYP2C9—Paclitaxel—kidney cancer	0.0245	0.0376	CbGbCtD
Pranlukast—CYP3A4—Pazopanib—kidney cancer	0.0218	0.0335	CbGbCtD
Pranlukast—CYP2C9—Sorafenib—kidney cancer	0.0217	0.0334	CbGbCtD
Pranlukast—CYP3A4—Erlotinib—kidney cancer	0.0156	0.0239	CbGbCtD
Pranlukast—CYP3A4—Paclitaxel—kidney cancer	0.0142	0.0219	CbGbCtD
Pranlukast—CYP3A4—Sorafenib—kidney cancer	0.0126	0.0194	CbGbCtD
Pranlukast—CYP3A4—Vinblastine—kidney cancer	0.0125	0.0192	CbGbCtD
Pranlukast—CYP3A4—Vincristine—kidney cancer	0.0123	0.0188	CbGbCtD
Pranlukast—CYP3A4—Sunitinib—kidney cancer	0.0102	0.0157	CbGbCtD
Pranlukast—CYP3A4—Doxorubicin—kidney cancer	0.00767	0.0118	CbGbCtD
Pranlukast—MUC2—renal system—kidney cancer	0.00666	0.148	CbGeAlD
Pranlukast—MUC2—gonad—kidney cancer	0.00597	0.132	CbGeAlD
Pranlukast—CYP2C9—urine—kidney cancer	0.00406	0.09	CbGeAlD
Pranlukast—NFKB1—renal system—kidney cancer	0.00379	0.0842	CbGeAlD
Pranlukast—NFKB1—kidney—kidney cancer	0.00367	0.0814	CbGeAlD
Pranlukast—NFKB1—cortex of kidney—kidney cancer	0.00357	0.0793	CbGeAlD
Pranlukast—NFKB1—gonad—kidney cancer	0.0034	0.0755	CbGeAlD
Pranlukast—NFKB1—cardiac atrium—kidney cancer	0.0034	0.0754	CbGeAlD
Pranlukast—CYP3A4—urine—kidney cancer	0.00309	0.0686	CbGeAlD
Pranlukast—ABCC2—nephron tubule—kidney cancer	0.00164	0.0364	CbGeAlD
Pranlukast—Candesartan—PTGS1—kidney cancer	0.00156	0.673	CrCbGaD
Pranlukast—ABCC2—renal system—kidney cancer	0.00149	0.0331	CbGeAlD
Pranlukast—ABCC2—kidney—kidney cancer	0.00144	0.032	CbGeAlD
Pranlukast—ABCC2—cortex of kidney—kidney cancer	0.0014	0.0311	CbGeAlD
Pranlukast—Candesartan—ABCB1—kidney cancer	0.000758	0.327	CrCbGaD
Pranlukast—CYP3A4—renal system—kidney cancer	0.000757	0.0168	CbGeAlD
Pranlukast—CYP3A4—kidney—kidney cancer	0.000732	0.0162	CbGeAlD
Pranlukast—NFKB1—Immune System—IFNA2—kidney cancer	3.24e-05	0.000107	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1R—kidney cancer	3.22e-05	0.000107	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MET—kidney cancer	3.21e-05	0.000107	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—KRAS—kidney cancer	3.18e-05	0.000106	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KRAS—kidney cancer	3.13e-05	0.000104	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RAF1—kidney cancer	3.12e-05	0.000103	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—MAPK3—kidney cancer	3.11e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RELA—kidney cancer	3.1e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDH1—kidney cancer	3.1e-05	0.000103	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—RAF1—kidney cancer	3.1e-05	0.000103	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—POMC—kidney cancer	3.09e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ERBB2—kidney cancer	3.08e-05	0.000102	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ITPR2—kidney cancer	3.06e-05	0.000102	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—kidney cancer	3.06e-05	0.000102	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—BRAF—kidney cancer	3.05e-05	0.000101	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.02e-05	0.0001	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—kidney cancer	2.96e-05	9.83e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—MAPK1—kidney cancer	2.96e-05	9.83e-05	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.92e-05	9.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—PIK3CA—kidney cancer	2.92e-05	9.69e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—PIK3CA—kidney cancer	2.87e-05	9.53e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—MAPK3—kidney cancer	2.84e-05	9.44e-05	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—PIK3CA—kidney cancer	2.83e-05	9.39e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—KRAS—kidney cancer	2.8e-05	9.28e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.79e-05	9.24e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—kidney cancer	2.78e-05	9.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CTNNA1—kidney cancer	2.78e-05	9.21e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HSPB1—kidney cancer	2.76e-05	9.16e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EIF4EBP1—kidney cancer	2.76e-05	9.16e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.76e-05	9.16e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—RAF1—kidney cancer	2.75e-05	9.13e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PDHB—kidney cancer	2.75e-05	9.13e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.75e-05	9.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—POMC—kidney cancer	2.74e-05	9.1e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—RELA—kidney cancer	2.74e-05	9.09e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ERBB2—kidney cancer	2.72e-05	9.04e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD8A—kidney cancer	2.72e-05	9.03e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—MAPK1—kidney cancer	2.71e-05	8.98e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CTNNB1—kidney cancer	2.7e-05	8.95e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MTOR—kidney cancer	2.69e-05	8.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD4—kidney cancer	2.68e-05	8.9e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HIF1A—kidney cancer	2.65e-05	8.79e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RAF1—kidney cancer	2.64e-05	8.77e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TSC2—kidney cancer	2.64e-05	8.76e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RELA—kidney cancer	2.63e-05	8.73e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ERBB2—kidney cancer	2.61e-05	8.68e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CCBL1—kidney cancer	2.59e-05	8.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—MTOR—kidney cancer	2.58e-05	8.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD4—kidney cancer	2.58e-05	8.55e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PIK3CA—kidney cancer	2.57e-05	8.53e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ANXA1—kidney cancer	2.57e-05	8.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PSMD7—kidney cancer	2.57e-05	8.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSC1—kidney cancer	2.57e-05	8.52e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.56e-05	8.49e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—KRAS—kidney cancer	2.56e-05	8.48e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RAF1—kidney cancer	2.55e-05	8.46e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RELA—kidney cancer	2.54e-05	8.43e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KDR—kidney cancer	2.53e-05	8.4e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.52e-05	8.38e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ERBB2—kidney cancer	2.52e-05	8.37e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CDKN1B—kidney cancer	2.52e-05	8.37e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MTOR—kidney cancer	2.49e-05	8.26e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FLT1—kidney cancer	2.48e-05	8.25e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.43e-05	8.05e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDKN1B—kidney cancer	2.42e-05	8.04e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—JUN—kidney cancer	2.4e-05	7.97e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.39e-05	7.94e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CTNNB1—kidney cancer	2.38e-05	7.91e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—kidney cancer	2.37e-05	7.88e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RAF1—kidney cancer	2.37e-05	7.88e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RELA—kidney cancer	2.36e-05	7.85e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ERBB2—kidney cancer	2.35e-05	7.8e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—PIK3CA—kidney cancer	2.35e-05	7.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.34e-05	7.76e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDKN1B—kidney cancer	2.34e-05	7.76e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APC—kidney cancer	2.33e-05	7.74e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KIT—kidney cancer	2.33e-05	7.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PTEN—kidney cancer	2.32e-05	7.71e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TSC2—kidney cancer	2.31e-05	7.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—JUNB—kidney cancer	2.3e-05	7.64e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PAK1—kidney cancer	2.3e-05	7.64e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—kidney cancer	2.29e-05	7.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MAPK3—kidney cancer	2.25e-05	7.46e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.24e-05	7.44e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPAT—kidney cancer	2.24e-05	7.44e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—MAPK3—kidney cancer	2.23e-05	7.41e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PTEN—kidney cancer	2.23e-05	7.4e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCND1—kidney cancer	2.23e-05	7.4e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—JUN—kidney cancer	2.22e-05	7.38e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—POMC—kidney cancer	2.22e-05	7.37e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.21e-05	7.35e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CTNNB1—kidney cancer	2.21e-05	7.33e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.19e-05	7.28e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—BRAF—kidney cancer	2.19e-05	7.28e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTEN—kidney cancer	2.15e-05	7.14e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MAPK1—kidney cancer	2.14e-05	7.09e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ACY1—kidney cancer	2.13e-05	7.08e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—MAPK1—kidney cancer	2.13e-05	7.05e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APRT—kidney cancer	2.09e-05	6.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FH—kidney cancer	2.09e-05	6.92e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CTNNB1—kidney cancer	2.06e-05	6.82e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KIT—kidney cancer	2.04e-05	6.78e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.04e-05	6.76e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—kidney cancer	2.03e-05	6.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KRAS—kidney cancer	2.02e-05	6.7e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—KRAS—kidney cancer	2.01e-05	6.66e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MAPK3—kidney cancer	1.98e-05	6.58e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPC3—kidney cancer	1.96e-05	6.51e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—kidney cancer	1.94e-05	6.45e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CA2—kidney cancer	1.91e-05	6.33e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MAPK1—kidney cancer	1.89e-05	6.26e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF2—kidney cancer	1.88e-05	6.25e-05	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.88e-05	6.24e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDH1—kidney cancer	1.88e-05	6.24e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN2B—kidney cancer	1.87e-05	6.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALAD—kidney cancer	1.86e-05	6.17e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PIK3CA—kidney cancer	1.84e-05	6.12e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAPK3—kidney cancer	1.84e-05	6.1e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RAF1—kidney cancer	1.83e-05	6.07e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RELA—kidney cancer	1.82e-05	6.05e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1R—kidney cancer	1.82e-05	6.04e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PDHB—kidney cancer	1.81e-05	6.02e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.81e-05	6.02e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ERBB2—kidney cancer	1.81e-05	6.01e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—kidney cancer	1.81e-05	6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—POMC—kidney cancer	1.81e-05	6e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MYC—kidney cancer	1.79e-05	5.93e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MTOR—kidney cancer	1.79e-05	5.93e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KRAS—kidney cancer	1.78e-05	5.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.77e-05	5.88e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAPK1—kidney cancer	1.75e-05	5.81e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KRAS—kidney cancer	1.71e-05	5.68e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MAPK3—kidney cancer	1.71e-05	5.68e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CCBL1—kidney cancer	1.71e-05	5.66e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PGK1—kidney cancer	1.7e-05	5.64e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.7e-05	5.64e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDKN1B—kidney cancer	1.68e-05	5.57e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LDHB—kidney cancer	1.67e-05	5.53e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KRAS—kidney cancer	1.65e-05	5.48e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—kidney cancer	1.64e-05	5.45e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PIK3CA—kidney cancer	1.64e-05	5.44e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MAPK1—kidney cancer	1.63e-05	5.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RAF1—kidney cancer	1.6e-05	5.32e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—kidney cancer	1.6e-05	5.31e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—JUN—kidney cancer	1.6e-05	5.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RELA—kidney cancer	1.6e-05	5.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERBB2—kidney cancer	1.59e-05	5.26e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CTNNB1—kidney cancer	1.58e-05	5.26e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PIK3CA—kidney cancer	1.57e-05	5.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MTOR—kidney cancer	1.57e-05	5.19e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD4—kidney cancer	1.56e-05	5.18e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTEN—kidney cancer	1.54e-05	5.13e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KRAS—kidney cancer	1.54e-05	5.1e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PIK3CA—kidney cancer	1.52e-05	5.04e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HIF1A—kidney cancer	1.5e-05	4.97e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSC2—kidney cancer	1.5e-05	4.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPAT—kidney cancer	1.48e-05	4.91e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.48e-05	4.91e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDKN1B—kidney cancer	1.47e-05	4.87e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—kidney cancer	1.47e-05	4.87e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CA9—kidney cancer	1.45e-05	4.8e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—kidney cancer	1.44e-05	4.77e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KDR—kidney cancer	1.43e-05	4.76e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.41e-05	4.69e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—JUN—kidney cancer	1.4e-05	4.64e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—kidney cancer	1.39e-05	4.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTNNB1—kidney cancer	1.39e-05	4.6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APRT—kidney cancer	1.38e-05	4.56e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FH—kidney cancer	1.38e-05	4.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTEN—kidney cancer	1.35e-05	4.49e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KIT—kidney cancer	1.32e-05	4.38e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APC—kidney cancer	1.32e-05	4.38e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK3—kidney cancer	1.32e-05	4.38e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPC3—kidney cancer	1.29e-05	4.29e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MYC—kidney cancer	1.28e-05	4.26e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CA2—kidney cancer	1.26e-05	4.17e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—kidney cancer	1.26e-05	4.17e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK1—kidney cancer	1.26e-05	4.17e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BRAF—kidney cancer	1.24e-05	4.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CRABP1—kidney cancer	1.23e-05	4.08e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALAD—kidney cancer	1.23e-05	4.07e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.2e-05	3.97e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KRAS—kidney cancer	1.19e-05	3.94e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.17e-05	3.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK3—kidney cancer	1.16e-05	3.83e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ITPR2—kidney cancer	1.14e-05	3.79e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PGK1—kidney cancer	1.12e-05	3.72e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.12e-05	3.72e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK1—kidney cancer	1.1e-05	3.65e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LDHB—kidney cancer	1.1e-05	3.65e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PIK3CA—kidney cancer	1.09e-05	3.62e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—kidney cancer	1.05e-05	3.5e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.05e-05	3.5e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ACHE—kidney cancer	1.04e-05	3.46e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTT1—kidney cancer	1.04e-05	3.46e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KRAS—kidney cancer	1.04e-05	3.45e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RAF1—kidney cancer	1.04e-05	3.44e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RELA—kidney cancer	1.03e-05	3.42e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ERBB2—kidney cancer	1.03e-05	3.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MTOR—kidney cancer	1.01e-05	3.36e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SCARB1—kidney cancer	9.86e-06	3.27e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS1—kidney cancer	9.76e-06	3.24e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PSMD7—kidney cancer	9.57e-06	3.18e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PIK3CA—kidney cancer	9.54e-06	3.17e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CA9—kidney cancer	9.53e-06	3.16e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN1B—kidney cancer	9.5e-06	3.15e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—kidney cancer	9.29e-06	3.08e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—BCHE—kidney cancer	9.08e-06	3.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—kidney cancer	9.06e-06	3.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—JUN—kidney cancer	9.04e-06	3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CTNNB1—kidney cancer	8.97e-06	2.98e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC5A5—kidney cancer	8.97e-06	2.98e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTEN—kidney cancer	8.74e-06	2.9e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC2A1—kidney cancer	8.66e-06	2.87e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.4e-06	2.79e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CRABP1—kidney cancer	8.11e-06	2.69e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—kidney cancer	7.9e-06	2.62e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ITPR2—kidney cancer	7.54e-06	2.5e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK3—kidney cancer	7.47e-06	2.48e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.33e-06	2.43e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MYC—kidney cancer	7.27e-06	2.41e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTP1—kidney cancer	7.22e-06	2.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK1—kidney cancer	7.11e-06	2.36e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTT1—kidney cancer	6.87e-06	2.28e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ACHE—kidney cancer	6.87e-06	2.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCB1—kidney cancer	6.84e-06	2.27e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KRAS—kidney cancer	6.71e-06	2.23e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—kidney cancer	6.64e-06	2.2e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SCARB1—kidney cancer	6.5e-06	2.16e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS1—kidney cancer	6.44e-06	2.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PSMD7—kidney cancer	6.31e-06	2.1e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1A1—kidney cancer	6.29e-06	2.09e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PIK3CA—kidney cancer	6.17e-06	2.05e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—BCHE—kidney cancer	5.99e-06	1.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—kidney cancer	5.97e-06	1.98e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.91e-06	1.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.71e-06	1.9e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.17e-06	1.72e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTP1—kidney cancer	4.76e-06	1.58e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—kidney cancer	4.69e-06	1.56e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCB1—kidney cancer	4.51e-06	1.5e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—kidney cancer	4.38e-06	1.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.15e-06	1.38e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—kidney cancer	3.74e-06	1.24e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTEN—kidney cancer	3.26e-06	1.08e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—kidney cancer	3.09e-06	1.03e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—kidney cancer	2.47e-06	8.19e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.3e-06	7.64e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTEN—kidney cancer	2.15e-06	7.14e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.52e-06	5.04e-06	CbGpPWpGaD
